tiprankstipranks
Trending News
More News >
HTG Molecular Diagnostics (HTGMQ)
OTHER OTC:HTGMQ
US Market

HTG Molecular Diagnostics (HTGMQ) Price & Analysis

Compare
459 Followers

HTGMQ Stock Chart & Stats

$0.01
>-$0.01(-99.00%)
At close: 4:00 PM EST
$0.01
>-$0.01(-99.00%)

HTGMQ FAQ

What was HTG Molecular Diagnostics’s price range in the past 12 months?
HTG Molecular Diagnostics lowest stock price was <$0.01 and its highest was $0.45 in the past 12 months.
    What is HTG Molecular Diagnostics’s market cap?
    HTG Molecular Diagnostics’s market cap is $221.00.
      When is HTG Molecular Diagnostics’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were HTG Molecular Diagnostics’s earnings last quarter?
      Currently, no data Available
      Is HTG Molecular Diagnostics overvalued?
      According to Wall Street analysts HTG Molecular Diagnostics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does HTG Molecular Diagnostics pay dividends?
        HTG Molecular Diagnostics does not currently pay dividends.
        What is HTG Molecular Diagnostics’s EPS estimate?
        HTG Molecular Diagnostics’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does HTG Molecular Diagnostics have?
        HTG Molecular Diagnostics has 2,214,233 shares outstanding.
          What happened to HTG Molecular Diagnostics’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of HTG Molecular Diagnostics?
          Currently, no hedge funds are holding shares in HTGMQ
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            HTG Molecular Diagnostics

            HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq Oncology Biomarker Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona. On June 5, 2023, HTG Molecular Diagnostics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

            HTG Molecular Diagnostics (HTGMQ) Earnings & Revenues

            Similar Stocks
            Company
            Price & Change
            Follow
            ENDRA Life Sciences
            Intelligent Bio Solutions
            BioNexus Gene Lab Corp
            Mainz Biomed B.V.
            bioAffinity Technologies, Inc.

            Ownership Overview

            0.05%99.95%
            Insiders
            Mutual Funds
            0.05% Other Institutional Investors
            99.95% Public Companies and
            Individual Investors

            Options Prices

            Currently, No data available
            ---
            Popular Stocks